Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avanos Medical, Inc. Common Stock (NY: AVNS )

15.05 -0.16 (-1.05%)
Official Closing Price Updated: 7:00 PM EST, Feb 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avanos Medical, Inc. Common Stock

< Previous 1 2 Next >
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Avanos Medical Earnings Preview
Via Benzinga
(AVNS) - Analyzing Avanos Medical's Short Interest
Via Benzinga
AVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024
AVNS stock results show that Avanos Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
Via Benzinga
Earnings Outlook For Avanos Medical
Via Benzinga
Avanos Medical Divests Respiratory Health Business To SunMed
Avanos Medical, Inc. (NYSE: AVNS)  
Via Benzinga
Avanos Medical Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap: Avanos Medical Q1 Earnings
Via Benzinga
Garmin, Apollo Global Management, Trane Technologies, Scotts Miracle-Gro And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones falling more than 30 points on Wednesday. Here are some big stocks recording gains in today’s session. TG Therapeutics, Inc. (NASDAQ: TGTX) shares jumped... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Via Benzinga
Looking Into Avanos Medical's Return On Invested Capital
Via Benzinga
Earnings Outlook For Avanos Medical
Via Benzinga
Recap: Avanos Medical Q3 Earnings
Avanos Medical (NYSE:AVNS) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Avanos Medical: Q2 Earnings Insights
  Avanos Medical (NYSE:AVNS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
Estee Lauder, NerdWallet, Sprout Social And Other Big Stocks Moving Lower On Wednesday
U.S. stocks mostly traded higher, but the Dow Jones lost around 19 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Avanos Medical Recalls Certain BALLARD ACCESS Closed Suction Systems For Pediatric Use Citing Ventilation Risk
Via Benzinga
Expert Ratings for Avanos Medical
Over the past 3 months, 4 analysts have published their opinion on Avanos Medical (NYSE:AVNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Recap: Avanos Medical Q4 Earnings
Avanos Medical (NYSE:AVNS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
7 Safe Small-Cap Stocks to Buy Now
Safe small-cap stocks might seem like something of an oxymoron. But these equities provide safety and growth potential nevertheless. 
Via InvestorPlace
7 Undervalued Small-Cap Stocks to Buy Now
These undervalued small-cap stocks to buy do have value and could outperform in both the short term and long term. 
Via InvestorPlace
Recap: Avanos Medical Q1 Earnings
Avanos Medical (NYSE:AVNS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Avanos Medical reported in-line... 
Via Benzinga
Avanos Medical's Earnings Outlook
Avanos Medical (NYSE:AVNS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Avanos... 
Via Benzinga
Avanos Medical Earnings Conference Call Is Coming Up, Here's What You Need To Know
Avanos Medical (NYSE:AVNS) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend Avanos Medical (AVNS) Conference Call Follow this link to access... 
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
Avanos Medical Earnings Preview
Avanos Medical (NYSE:AVNS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.